Ipsen
IPN
ISIN FR0010259150 / Valor 2348805
Ipsen
UMushroom community rating:
About company
Ipsen is a France-based, research-driven biopharmaceutical company that develops, manufactures and commercializes specialty-care medicines with a focus on oncology, rare diseases and neuroscience. Its marketed portfolio includes treatments such as Somatuline (lanreotide) for neuroendocrine tumors and acromegaly, Decapeptyl (triptorelin) in endocrine and oncology indications, and Dysport (abobotulinumtoxinA) for certain neurological and aesthetic uses; the group builds its business through internal R&D, acquisitions and licensing partnerships to advance a pipeline of targeted and rare-disease therapies and to support global commercial operations across Europe, North America and Asia.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
15822 M
Market cap (USD)
86,307
Daily traded volume (Shares)
110.8 / 109.9
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
